ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Share Price
Equities
1541
CNE100006624
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.58 HKD | -2.15% | -1.09% | -51.24% |
Sales 2023 | 386K 53.43K 417K 4.46M | Sales 2024 * | 588K 81.46K 636K 6.8M | Capitalization | 5.04B 698M 5.46B 58.3B |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 25,574 x |
Net cash position 2023 | 297M 41.05M 321M 3.43B | Net cash position 2024 * | 494M 68.36M 534M 5.71B | EV / Sales 2024 * | 7,732 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 145 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 30.46% |
1 day | -2.15% | ||
1 week | -1.09% | ||
Current month | -4.20% | ||
1 month | -5.32% | ||
3 months | -26.36% | ||
6 months | -46.00% | ||
Current year | -51.24% |
Managers | Title | Age | Since |
---|---|---|---|
Wen Zhi Tian
CEO | Chief Executive Officer | - | 01/15/01 |
Qi Ying Lu
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Song Li
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Tat Yeung
BRD | Director/Board Member | 55 | - |
Zhi Hua Yu
BRD | Director/Board Member | 56 | - |
Wen Zhi Tian
CEO | Chief Executive Officer | - | 01/15/01 |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 14.58 | -2.15% | 141,400 |
09/24/09 | 14.9 | -0.53% | 193,400 |
08/24/08 | 14.98 | +3.88% | 140,800 |
07/24/07 | 14.42 | +0.28% | 137,200 |
06/24/06 | 14.38 | +2.28% | 139,600 |
Delayed Quote Hong Kong S.E., May 10, 2024 at 01:38 pm IST
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.24% | 698M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- 1541 Stock